Your browser doesn't support javascript.
loading
Abnormal Thyroid Function Laboratory Results Caused by Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressant Treatment.
Liao, Huijuan; Rosenthal, David S; Kumar, Salini C.
Afiliación
  • Liao H; Division of Endocrinology, Nassau University Medical Center, 2201 Hempstead Turnpike, East Meadow, NY 11554, USA.
  • Rosenthal DS; Division of Endocrinology, Nassau University Medical Center, 2201 Hempstead Turnpike, East Meadow, NY 11554, USA.
  • Kumar SC; Division of Endocrinology, Nassau University Medical Center, 2201 Hempstead Turnpike, East Meadow, NY 11554, USA.
Case Rep Psychiatry ; 2023: 7170564, 2023.
Article en En | MEDLINE | ID: mdl-37215167
Mental health issues, especially depressive disorders, are major burdens to the health care systems. This has been more pronounced since the onset of the COVID-19 pandemic. Selective serotonin reuptake inhibitors (SSRIs) are often prescribed for depression. Uncommonly appreciated, however, are the adverse effects these agents may have on thyroid function laboratory test results as well as the clinical thyroidal functional status of such patients, which may lead to erroneous diagnoses and inappropriate treatments. We report on a depressed woman who developed abnormal thyroid biochemical laboratory reports during fluoxetine therapy. After changing to the serotonin and norepinephrine reuptake inhibitor (SNRI) venlafaxine, the thyroid laboratory reports were normalized. In light of this, we wish to alert treating clinicians to this potential significant adverse effect.

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Case Rep Psychiatry Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Case Rep Psychiatry Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos